Annual Drug Patent Expirations for ENSTILAR
Enstilar is a drug marketed by Leo Pharma As and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for ENSTILAR.
This drug has eigthy-two patent family members in thirty-four countries.
The generic ingredient in ENSTILAR is betamethasone dipropionate; calcipotriene. One supplier is listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com